5%

Amneal gets ANDA approval for acyclovir cream, 5%

Amneal gets ANDA approval for acyclovir cream, 5%

BRIDGEWATER, N.J. —Amneal Pharmaceuticals announced that it has received approval for its Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug Administration (FDA) for acyclovir cream, 5%. Acyclovir cream, 5%, is the generic version of Zovirax for treatment of recurrent herpes labialis (cold sores) in immunocompetent adults and adolescents 12 years of age